RecruitingNCT06495177

European Survey of Cardiovascular Disease Prevention, Diabetes and Chronic Kidney Disease (EUROASPIRE VI)

European Survey of Cardiovascular Disease Prevention, Diabetes and Chronic Kidney Disease

Sponsor

European Society of Cardiology

Enrollment

8,000 participants

Start Date

Jun 7, 2024

Study Type

OBSERVATIONAL

Conditions

Coronary Disease Acute Coronary Syndrome Unstable Angina ST Elevation Myocardial Infarction Non-ST Elevation Myocardial Infarction

Summary

The goal of this observational study is to provide a unique European picture of preventive action by cardiologists, other specialists and primary care physicians looking after patients with coronary heart disease (CHD), individuals at high cardiovascular disease risk and all those with hypertension, dyslipidaemia (including familial hypercholesterolaemia), diabetes and dysglycaemia and chronic kidney disease (CKD) and determine whether the European guidelines on cardiovascular disease prevention, hypertension, lipids, diabetes and chronic kidney disease are being followed.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a large European survey study collecting data on how well heart disease, diabetes, and chronic kidney disease are being prevented and managed in patients across multiple countries, to identify gaps and improve care standards. **You may be eligible if...** - You are 18 or older - You have had a recent heart event (such as a heart attack, unstable angina, or a procedure to open blocked heart arteries) in the past 6–24 months - OR you are at high risk for heart disease (e.g., due to diabetes, high blood pressure, or high cholesterol) - OR you have chronic kidney disease - You have signed informed consent **You may NOT be eligible if...** - Your relevant event or diagnosis occurred less than 6 months or more than 24 months ago - You are unable to participate in an interview Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.